These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 2481585

  • 1. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.
    Danielian S, Fagard R, Alcover A, Acuto O, Fischer S.
    Eur J Immunol; 1989 Dec; 19(12):2183-9. PubMed ID: 2481585
    [Abstract] [Full Text] [Related]

  • 2. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
    Danielian S, Alcover A, Polissard L, Stefanescu M, Acuto O, Fischer S, Fagard R.
    Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
    [Abstract] [Full Text] [Related]

  • 3. The tyrosine kinase activity of p56lck is increased in human T cells activated via CD2.
    Danielian S, Fagard R, Alcover A, Acuto O, Fischer S.
    Eur J Immunol; 1991 Aug; 21(8):1967-70. PubMed ID: 1678351
    [Abstract] [Full Text] [Related]

  • 4. Stimulation via CD3-Ti but not CD2 induces rapid tyrosine phosphorylation of a 68-kDa protein in the human Jurkat T cell line.
    Jin YJ, Kaplan DR, White M, Spagnoli GC, Roberts TM, Reinherz EL.
    J Immunol; 1990 Jan 15; 144(2):647-52. PubMed ID: 1688582
    [Abstract] [Full Text] [Related]

  • 5. Anti-CD2-induced tyrosine phosphorylation of T cell polypeptides is independent of the PMA-induced modification of p56lck.
    Breithaupt TB, Rivera-Quiñones C, Molina C, Báez I, Eylar EH.
    Cell Immunol; 1993 Mar 15; 147(1):139-47. PubMed ID: 8096437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
    Kanner SB, Damle NK, Blake J, Aruffo A, Ledbetter JA.
    J Immunol; 1992 Apr 01; 148(7):2023-9. PubMed ID: 1372020
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA, Kanner SB, Schieven GL, Thompson CB, Ledbetter JA.
    Eur J Immunol; 1992 Feb 01; 22(2):551-7. PubMed ID: 1371471
    [Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C, Mazerolles F, Soula M, Fagard R, Graton S, Meloche S, Sekaly RP, Fischer A.
    Eur J Immunol; 1993 Mar 01; 23(3):600-7. PubMed ID: 7680610
    [Abstract] [Full Text] [Related]

  • 15. The T cell receptor/CD3 complex and CD2 stimulate the tyrosine phosphorylation of indistinguishable patterns of polypeptides in the human T leukemic cell line Jurkat.
    Ley SC, Davies AA, Druker B, Crumpton MJ.
    Eur J Immunol; 1991 Sep 01; 21(9):2203-9. PubMed ID: 1679714
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N, Miceli MC, Parnes JR, Veillette A.
    Nature; 1991 Mar 07; 350(6313):62-6. PubMed ID: 1706070
    [Abstract] [Full Text] [Related]

  • 17. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
    Samstag Y, Bader A, Meuer SC.
    J Immunol; 1991 Aug 01; 147(3):788-94. PubMed ID: 1677669
    [Abstract] [Full Text] [Related]

  • 18. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG, Gervais FG, Weil R, Davidson D, Gish GD, Veillette A.
    Oncogene; 1993 Oct 01; 8(10):2765-72. PubMed ID: 7690927
    [Abstract] [Full Text] [Related]

  • 19. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ, Abraham RT, Dick CJ, Leibson PJ.
    J Immunol; 1990 Sep 01; 145(5):1490-7. PubMed ID: 1696599
    [Abstract] [Full Text] [Related]

  • 20. Regulation of D-3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens.
    Ward SG, Ley SC, MacPhee C, Cantrell DA.
    Eur J Immunol; 1992 Jan 01; 22(1):45-9. PubMed ID: 1346114
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.